Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...] …
Category: Pharma Industry
Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...] …
Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...] …
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...] …
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...] …
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...] …
Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...] …
Drugmaker Novo Nordisk announced it is providing 340B covered entities 12-months-worth of refunds on four drug products including two of [...] …
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...] …